TCMBANKIN004210 |
1-methoxy-2-hydroxyanthraquinone |
Anthraquinone, 2-hydroxy-1-methoxy-; Alizarin-1-methylether; 2-Hydroxy-1-methoxy-anthraquinone; AIDS098147; Alizarin-1-methyl ether; 2-hydroxy-1-methoxy-anthracene-9,10-dione; 9,10-Anthracenedione, 2-hydroxy-1-methoxy-; 2-hydroxy-1-methoxy-9,10-anthraquinone; 6170-06-5; Alizarin 1-methyl ether; AIDS-098147; 2-hydroxy-1-methoxyanthracene-9,10-dione |
C15H10O4 |
254.24 g/mol |
COC1=C(C=CC2=C1C(=O)C3=CC=CC=C3C2=O)O |
TCMBANKIN021808 |
juzunal |
SCHEMBL16226525; 3,5-dihydroxy-1-methoxy-9,10-dioxoanthracene-2-carbaldehyde; AC1NSX8M |
C16H10O6 |
298.25 g/mol |
COC1=C2C(=CC(=C1C=O)O)C(=O)C3=C(C2=O)C=CC=C3O |
TCMBANKIN024138 |
Nordamnacanthal |
2-Anthracenecarboxaldehyde, 9,10-dihydro-1,3-dihydroxy-9,10-dioxo-; AIDS098139; AIDS-098139; 1,3-dihydroxy-9,10-dioxo-anthracene-2-carbaldehyde; nordamnacanthal; 1,3-dihydroxy-9,10-dioxo-2-anthracenecarboxaldehyde; nordamnacanthal ; 1,3-dihydroxy-9,10-diketo-anthracene-2-carbaldehyde; CCRIS 6442; 3736-59-2; 1,3-dihydroxy-9,10-dioxoanthracene-2-carbaldehyde |
C15H8O5 |
268.22 |
C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C=O)O |
TCMBANKIN024301 |
norjuzunal |
1,3,5-trihydroxy-9,10-dioxoanthracene-2-carbaldehyde; 4430-69-7; 1,3,5-Trihydroxyanthraquinone-2-carboxaldehyde; SCHEMBL16226906; AC1NSZ73 |
C15H8O6 |
284.22 g/mol |
C1=CC2=C(C(=C1)O)C(=O)C3=CC(=C(C(=C3C2=O)O)C=O)O |
TCMBANKIN031265 |
damnacanthal |
damnacanthal |
C16H10O5 |
282.25 g/mol |
COC1=C2C(=CC(=C1C=O)O)C(=O)C3=CC=CC=C3C2=O |
TCMBANKIN032969 |
damnacanthol |
|
C16H12O5 |
284.26 g/mol |
COC1=C2C(=CC(=C1CO)O)C(=O)C3=CC=CC=C3C2=O |
TCMBANKIN034173 |
damsin |
|
C15H20O3 |
248.32 g/mol |
CC1CCC2C(C3(C1CCC3=O)C)OC(=O)C2=C |
TCMBANKIN034394 |
alizarin-1-methyl ether |
alizarin-1-methylether; alizarin 1-methylether |
C15H10O5 |
270.24 g/mol |
COC1=C(C(=C2C(=C1)C(=O)C3=CC=CC=C3C2=O)O)O |
TCMBANKIN036966 |
Norketoagarofuran |
nor-ketoagarofuran |
|
222.32 g/mol |
|
TCMBANKIN040291 |
7-Hydroxyaloin |
|
C21H22O10 |
434.393 |
c1(O[H])c(O[H])c(C(=O)c(c(O[H])c([H])c(C([H])([H])O[H])c2[H])c2[C@]3([H])[C@@]4([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O4)c3c([H])c1[H] |
TCMBANKIN040532 |
Kadsudilactone |
|
|
468.7 g/mol |
|
TCMBANKIN044375 |
18-nordehydroabietan-4alpha-ol |
18-nordehydroabietan-4α-ol |
C19H28O |
0 |
CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)O)C |
TCMBANKIN048228 |
2'beta,13alpha,14beta-trisdeacetylaustrotaxine |
2'β,13α,14β-trisdeacetylaustrotaxine |
C35H47NO10 |
|
|
TCMBANKIN058382 |
1-hydroxy-2-hydroxymethylanthraquinone |
BRN 2218948; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; 1-Hydroxy-2-hydroxymethylanthraquinone; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); Digiferrugineol; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; 1-hydroxy-2-methylol-9,10-anthraquinone; C10327; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; 24094-45-9;1-Hydroxy-2-hydroxymethylanthraquinone; MolPort-039-338-647; 24094-45-9; Deoxylucidin; CHEBI:4544; BG00960207; CHEMBL495276; BRN 2218948; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; C10327; ACM24094459; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); 1-Hydroxy-2-(hydroxymethyl)anthra-9,10-quinone #; AC1L1N7Z; DTXSID40178818; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; Digiferrugineol; ZINC4098663; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; LS-20690; JCZCSQSSSAHDCB-UHFFFAOYSA-N;Deoxylucidin;digiferrugineol |
C15H10O4 |
254.24 |
C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)CO)O |